Documentazione scientifica recente

• Malattie dell’Apparato Gastrointestinale e del Fegato Schlesinger and Fortran

• Primary liver cancers with nonalcoholic steatohepatitis. Hashizume H, Sato K, Takagi H, Hirokawa T, Kojima A, Sohara N, Kakizaki S, Mochida Y, Shimura T, Sunose Y, Ohwada S, Mori M. Eur J Gastroenterol Hepatol. 2007 Oct;19(10):827

• Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management, Yan E, Durazo F, Tong M, Hong K. Nutr Rev. 2007 Aug;65(8 Pt 1):376-84

• Pathogenesis and management issues for non-alcoholic fatty liver disease, Duvnjak M, Lerotić I, Barsić N, Tomasić V, Virović Jukić L, Velagić V. World J Gastroenterol. 2007 Sep 14;13(34):4539-50. Review.

• Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Pinzani M, Vizzutti F, Arena U, Marra F.  Nat Clin Pract Gastroenterol Hepatol. 2008 Feb;5(2):95-106.

• Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD). Yoneda M, Yoneda M, Mawatari H, Fujita K, Endo H, Iida H, Nozaki Y, Yonemitsu K, Higurashi T, Takahashi H, Kobayashi N, Kirikoshi H, Abe Y, Inamori M, Kubota K, Saito S, Tamano M, Hiraishi H, Maeyama S, Yamaguchi N, Togo S, Nakajima A. Dig Liver Dis. 2007 Dec 13

• Current treatments in nonalcoholic steatohepatitis. Torres DM, Harrison SA. Curr Treat Options Gastroenterol. 2007 Dec;10(6):425

• Current pharmacological treatment of nonalcoholic fatty liver. Portincasa P, Grattagliano I, Palmieri VO, Palasciano G. Curr Med Chem. 2006;13(24):2889-900

• Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Farrell GC, Larter CZ. Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112

• Incidence and natural course of fatty liver in the general population: the Dionysos study. Bedogni G, Miglioli L, Masutti F, Castiglione A, Crocè LS, Tiribelli C, Bellentani S. Hepatology. 2007 Nov;46(5):1387-91